THE NEW VERSION OF T2T (TREAT-TO-TARGET) FOR SPONDYLOARTHRITIDES
https://doi.org/10.14412/1995-4484-2017-572-575
Abstract
The communication briefly presents the updated version of treat-to- target (T2T) recommendations for spondyloarthritides.
About the Author
Sh. F. Erdes
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
34A, Kashirskoe Shosse, Moscow 115522
References
1. Smolen JS, Braun J, Dougados M, et al. Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force. Ann Rheum Dis. 2014;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419
2. Эрдес ШФ. Стратегия «Лечение до достижения цели». Научно-практическая ревматология. 2014;52(3):251-3 [Erdes ShF. «Treat-to-target» (T2T) strategy in spondyloarthritis. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014:52(3):251-3 (In Russ.)]. doi: 10.14412/1995-4484-2014-251-253
3. Smolen JS, Schö ls M, Braun J, et al. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis. Published Online First: 06 July 2017. doi: 10.1136/annrheumdis-2017-211734
Review
For citations:
Erdes Sh.F. THE NEW VERSION OF T2T (TREAT-TO-TARGET) FOR SPONDYLOARTHRITIDES. Rheumatology Science and Practice. 2017;55(5):572-575. (In Russ.) https://doi.org/10.14412/1995-4484-2017-572-575
Views:
761
Email this article 